ROCKWELL MEDICAL, INC. (RMTI): Nasdaq/NYSE listing notice — Rockwell Medical receives Nasdaq delisting notice for bid price below $1.00

ROCKWELL MEDICAL, INC.

Notice issued May 8, 2026 for failing to meet $1.00 minimum bid price over 30 consecutive business days.
Company has 180 calendar days (until November 4, 2026) to regain compliance.
To cure, closing bid price must be at least $1.00 for 10 consecutive business days.
Reverse stock split proposal included in 2026 Annual Meeting proxy to address the deficiency.
No immediate impact on listing; shares continue trading on Nasdaq Capital Market.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

ROCKWELL MEDICAL, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

May 8, 2026, Rockwell Medical, Inc. (the “Company”) received written notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price require

View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

ROCKWELL MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001628280-26-032987

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.